Evidence map›Paper›PMID 40235344›Full record

ArticlePharmacogenomics

Association of

Seval Küçükparmaksız, Dilek Kaya Akyüzlü, Selin Özkan Kotiloğlu, Mustafa Danışman

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmacogenomics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Seval KüçükparmaksızInstitute of Forensic Sciences, Ankara University, Ankara, Türkiye.
Dilek Kaya AkyüzlüInstitute of Forensic Sciences, Ankara University, Ankara, Türkiye.
Selin Özkan KotiloğluInstitute of Forensic Sciences, Ankara University, Ankara, Türkiye.
Mustafa DanışmanAlcohol and Drug Addiction Treatment Center, Ankara Training and Research Hospital AMATEM Clinic, Ankara, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe aim of this study is to find out the effect of

methodsIndividuals with OUD (

resultsA significant difference was observed between individuals with OUD and controls in view of the frequency of 'Ins/Del+Del/Del' genotypes of the

conclusionThe

Indexed as

Opioid-Related DisordersSuperoxide DismutaseSuperoxide Dismutase-1AdultCase-Control StudiesFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedPolymerase Chain ReactionPolymorphism, Restriction Fragment LengthPolymorphism, Single NucleotideSuperoxide Dismutase 2TurkeySOD1 protein, humanSuperoxide DismutaseSuperoxide Dismutase-1Superoxide Dismutase 2antioxidant enzymesinterindividual variabilityOpioid use disorderSOD1SOD2

Identifiers

PMID40235344
PMCPMC12164389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.